Atlas Trials

Vaxart

23 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Vaxart

RecordFirmDate
A Trial of a Norovirus G1.1 and G2.4 Vaccine Administered Orally to Healthy Participants Aged ≥ 18 Years and ≤ 80 Years Old (NCT06944717)Vaxart2025-03-03
A Study to Evaluate VXA-CoV2-3.3 COVID-19 Vaccine Against Currently Approved/Authorized mRNA COVID-19 Injectable Booster Vaccine in Adults Previously Immunized Against COVID-19 Infection (NCT06672055)Vaxart2024-10-08
A Study to Evaluate Vaxart's Oral Bivalent GI.1/GII.4 Norovirus Vaccine in Healthy Lactating Females and Their Nursing Infants (NCT07254728)Vaxart2023-10-27
A Study to Determine the Safety and Immunogenicity of Bivalent GI.1 and GII.4 Vaccines in Healthy Volunteers (NCT05626803)Vaxart2023-01-26
A Phase 1, Open-label, Safety and Immunogenicity Study of an Oral Multi-dose Administration Regimen With an Adenoviral-vector Based Tablet Norovirus Vaccine (VXA-G1.1-NN) Administered to Healthy Adult Volunteers (NCT05213728)Vaxart2022-01-24
Immunogenicity & Safety Study of Adenovirus Type 5 (AD5) Based Oral Norovirus Vaccines (NCT04875676)Vaxart2021-04-30
Ph 1b: Safety & Immunogenicity of Ad5 Based Oral Norovirus Vaccine (NCT04854746)Vaxart2021-04-26
Safety and Immunogenicity Trial of an Oral SARS-CoV-2 Vaccine (VXA-CoV2-1) for Prevention of COVID-19 in Healthy Adults and Boost (VXA-CoV2-1.1-S) at 1 Year Post Initial Vaccination in Subset of Subjects (NCT04563702)Vaxart2020-09-21
Safety & Immunogenicity Study of Ad5 Based Oral Norovirus Vaccines (NCT03897309)Vaxart2019-03-20

Track Vaxart automatically

Every clearance here is in the API, with alerts when new ones post.